首页> 外国专利> Pharmaceutical composition comprising beta oxihidroxido iron in High Load in a form suitable for oral administration containing at least one carbohydrate and / or Humic acid and its use in the treatment of hyperphosphataemia in patients with chronic renal failure, and procedimento pa

Pharmaceutical composition comprising beta oxihidroxido iron in High Load in a form suitable for oral administration containing at least one carbohydrate and / or Humic acid and its use in the treatment of hyperphosphataemia in patients with chronic renal failure, and procedimento pa

机译:包含高负荷量的β-羟肟基铁的药物组合物,其形式适合于口服给药,其中含有至少一种碳水化合物和/或腐殖酸,并且其用于治疗慢性肾功能衰竭和高脂血症的高磷血症

摘要

Pharmaceutical compositions for oral administration, in particular as a Delivery System for oral Direct ingestion or capable of disintegrating in the oral cavity, which comprises oxihidroxido high iron Load in claim 6: Composition according to any of the reiv Previous indications,Oxihidroxido characterized because the iron is in an amount of 10 to 80% by weight, preferably 30 to 65% by weight, expressed in relation to the total weight of the composition. Composition according to claim 8: any of the preceding Claims, characterized in that it comprises one or more agents, FLAVORING agents, Sweeteners, flavor Enhancers and / or colouring agents.Composition according to claim 12: any of the preceding Claims, characterized by also include one or more excipients such as super disintegrating, LUBRICANTS, antioxidants.Claim 1: Composition according to any of the preceding Claims, wherein lies in an intact form for ingestion or in a form of Rapid Disintegration, such as Chewable Tablets or Pills, dry powder, Granules, capsules or sachets containing this S Granules, wafers or tablets.Claim 21: Use of the composition according to any of the preceding claims for the manufacture of a Medicament for the treatment of patients with chronic renal failure.
机译:7.用于口服给药的药物组合物,特别是作为用于口服直接摄取或能够在口腔中崩解的递送系统的药物组合物,其包含奥昔洛酮高铁。7.权利要求6的组合物:根据任何一项前述的组合物,奥昔洛基的特征在于,所述铁相对于组合物的总重量,其含量为10至80重量%,优选30至65重量%。 9.根据权利要求8所述的组合物,其特征在于,其包含一种或多种试剂,调味剂,甜味剂,增香剂和/或着色剂。13.根据权利要求12所述的组合物,其特征在于,权利要求1:根据前述权利要求中任一项的组合物,其中处于完整形式以用于摄入或以快速崩解的形式存在,例如咀嚼片或丸剂, 21.含有上述S个颗粒,薄片或片剂的干粉,颗粒,胶囊或小袋。权利要求21:根据前述权利要求中任一项的组合物在制备用于治疗慢性肾衰竭患者的药物中的用途。

著录项

  • 公开/公告号AR069312A1

    专利类型

  • 公开/公告日2010-01-13

    原文格式PDF

  • 申请/专利权人 VIFOR (INTERNATIONAL) AG.;

    申请/专利号AR2008P104959

  • 发明设计人 PHILIPP ERIK;WEIBEL-FURER LUDWIG;

    申请日2008-11-13

  • 分类号A61K33/26;A61K31/047;A61K45/08;A61K31/7004;A61K31/715;A61K47/32;A61P13/00;A61P13/12;

  • 国家 AR

  • 入库时间 2022-08-21 18:47:31

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号